INTRODUCTION AND HYPOTHESIS: The primary aim of the study was to translate and validate a Polish version of the CONTILIFE, a quality of life questionnaire. The clinical validity of the CONTILIFE was assessed against the number of urinary leaks, Valsalva leak point pressure (VLPP), and maximum urethral closure pressure (MUCP). METHODS: One hundred women with stress urinary incontinence completed a Polish version of the CONTILIFE twice with a 4-day interval. RESULTS: Internal consistency (Cronbach's alpha= 0.94) and test-retest reliability of the instrument (ICC = 0.96) were very good. A significant relationship was found between all the CONTILIFE dimension scores, the CONTILIFE global score, and the number of urinary leaks per week. A less significant relationship was found between VLPP, MUCP, and CONTILIFE dimension and global scores. CONCLUSIONS: A Polish version of the CONTILIFE can be a reliable measure of quality of life in stress urinary incontinence patients.
INTRODUCTION AND HYPOTHESIS: The primary aim of the study was to translate and validate a Polish version of the CONTILIFE, a quality of life questionnaire. The clinical validity of the CONTILIFE was assessed against the number of urinary leaks, Valsalva leak point pressure (VLPP), and maximum urethral closure pressure (MUCP). METHODS: One hundred women with stress urinary incontinence completed a Polish version of the CONTILIFE twice with a 4-day interval. RESULTS: Internal consistency (Cronbach's alpha= 0.94) and test-retest reliability of the instrument (ICC = 0.96) were very good. A significant relationship was found between all the CONTILIFE dimension scores, the CONTILIFE global score, and the number of urinary leaks per week. A less significant relationship was found between VLPP, MUCP, and CONTILIFE dimension and global scores. CONCLUSIONS: A Polish version of the CONTILIFE can be a reliable measure of quality of life in stress urinary incontinencepatients.
Authors: Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein Journal: Neurourol Urodyn Date: 2002 Impact factor: 2.696
Authors: Werner Schäfer; Paul Abrams; Limin Liao; Anders Mattiasson; Francesco Pesce; Anders Spangberg; Arthur M Sterling; Norman R Zinner; Philip van Kerrebroeck Journal: Neurourol Urodyn Date: 2002 Impact factor: 2.696
Authors: Thierry Roumeguère; Th Quackels; R Bollens; A de Groote; A Zlotta; M Vanden Bossche; C Schulman Journal: Eur Urol Date: 2005-08-31 Impact factor: 20.096
Authors: Michael Albo; Lisa Wruck; Jan Baker; Linda Brubaker; Toby Chai; Kimberly J Dandreo; Ananias Diokno; Patricia Goode; Stephen Kraus; John W Kusek; Gary Lemack; Jerry Lowder; William Steers Journal: J Urol Date: 2007-05 Impact factor: 7.450
Authors: Chi Chiung Grace Chen; Christopher M Rooney; Marie Fidela R Paraiso; Steven D Kleeman; Mark D Walters; Mickey M Karram; Matthew D Barber Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2008-04-15
Authors: G Ghoniem; E Stanford; K Kenton; C Achtari; R Goldberg; T Mascarenhas; M Parekh; K Tamussino; S Tosson; G Lose; E Petri Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2007-11-17